Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
27 participants
INTERVENTIONAL
2015-03-31
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
In Vivo Efficacy Study of Patient Preoperative Preps
NCT02203591
In Vivo Preoperative Skin Preparation Persistence Evaluation
NCT03155178
In-vivo Efficacy Study of Patient Preoperative Preps
NCT01968356
In Vivo Preoperative Skin Preparation Efficacy Study Within a Defined Product Coverage Area
NCT03681990
In-vivo Efficacy of Patient Preoperative Prep
NCT02831998
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
3M CHG/IPA - Abdominal Region
Apply Chlorhexidine (CHG) 2% / Isopropyl alcohol (IPA) 70% for 30 seconds and allow to dry for 3 minutes.
3M CHG/IPA Surgical Skin Preparation - Abdominal Region
Chlorhexidine gluconate 2% / Isopropyl alcohol 70%
Normal Saline - Abdominal Region
Apply 0.9% sodium chloride with applicator for 30 seconds and allow to dry for 3 minutes.
Normal Saline - Abdominal Region
0.9% sodium chloride applied with foam applicator
3M CHG/IPA - Inguinal Region
Apply Chlorhexidine (CHG) 2% / Isopropyl alcohol (IPA) 70% for 30 seconds and allow to dry for 3 minutes.
3M CHG/IPA Surgical Skin Preparation - Inguinal Region
Chlorhexidine gluconate 2% / Isopropyl alcohol 70%
Normal Saline - Inguinal Region
Apply 0.9% sodium chloride with applicator for 30 seconds and allow to dry for 3 minutes.
Normal Saline - Inguinal Region
0.9% sodium chloride applied with foam applicator
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3M CHG/IPA Surgical Skin Preparation - Abdominal Region
Chlorhexidine gluconate 2% / Isopropyl alcohol 70%
Normal Saline - Abdominal Region
0.9% sodium chloride applied with foam applicator
3M CHG/IPA Surgical Skin Preparation - Inguinal Region
Chlorhexidine gluconate 2% / Isopropyl alcohol 70%
Normal Saline - Inguinal Region
0.9% sodium chloride applied with foam applicator
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects in good general health
* Minimum skin flora baseline requirements on abdomen and groin
Exclusion Criteria
* Topical antimicrobial exposure within 14 days prior to screening and treatment days
* Use of systemic or topical antibiotics, steroid medications, or any other products known to affect the normal microbial flora of the skin within 14 days prior to screening and treatment days
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
3M
INDUSTRY
Solventum US LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Muhammad H Bashir, MD, CCRP
Role: PRINCIPAL_INVESTIGATOR
MicroBioTest Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MicroBioTest
Sterling, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EM-05-013509
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.